Indeed, it has previously been shown that in nonsurgical interventional approaches to HCC treatment, pre-intervention AFP correlates with survival (Cerban et al. 2018); however, AFP has not yet been validated as a response prediction marker (Colli et al. 2021; Toader et al. 2019). Here, AFP is linked to hepatocellular carcinoma.